Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedSep 18, 2013MIC-CARN + B6/B12/LIDOCAINE 25/50/50/175MCG/1/0.1MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-980-2013Class IITerminatedSep 18, 2013METHYLPREDNISOLONE ACETATE 40 MG/ML and 80 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-979-2013Class IITerminatedSep 18, 2013METHYLCOBALAMIN 1 mg/mlLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-978-2013Class IITerminatedSep 18, 2013MAGNESIUM SULFATE 50% INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-977-2013Class IITerminatedSep 18, 2013MAGNESIUM CHLORIDE HEXAHYDRATE 20% INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-976-2013Class IITerminatedSep 18, 2013LIPOIC ACID 100 MG/ML and 200 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-975-2013Class IITerminatedSep 18, 2013LIPO-PLEX INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-974-2013Class IITerminatedSep 18, 2013LIDOCAINE MDV 1% INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-973-2013Class IITerminatedSep 18, 2013L-TRYPTOPHAN 300 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-972-2013Class IITerminatedSep 18, 2013KETOROLAC TROMETHAMINE 60 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-971-2013Class IITerminatedSep 18, 2013HYDROXYPROGESTERONE CAPROATE 250 MG/ML OIL INJ SOLNLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-970-2013Class IITerminatedSep 18, 2013HYDROXOCOBALAMINLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-969-2013Class IITerminatedSep 18, 2013HYALURONIDASE 150 U/ML and 200 U/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-968-2013Class IITerminatedSep 18, 2013HYDROGEN PEROXIDE 3% INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-967-2013Class IITerminatedSep 18, 2013H.C.G. (COMPOUNDED)Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-966-2013Class IITerminatedSep 18, 2013GLYCYRRHIZIC ACID 8 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-965-2013Class IITerminatedSep 18, 2013GLYCINE 50 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-964-2013Class IITerminatedSep 18, 2013GLUTATHIONE/METHYL/LIDO 100/25/20 MG/ML INJ SOLN and GLUTATHIONE/METHYL/LIDO 100/25/20MG/MLLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-963-2013Class IITerminatedSep 18, 2013GLUTATHIONE/LIDO 100MG/2%/MLLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-962-2013Class IITerminatedSep 18, 2013GLUTATHIONE 200 MG/MLLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-961-2013Class IITerminatedSep 18, 2013GLUTAMINE 100 MG/ML INJ SOLNLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-960-2013Class IITerminatedSep 18, 2013FUROSEMIDE 10 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-959-2013Class IITerminatedSep 18, 2013FREAMINE III ALT. 8.5% INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-958-2013Class IITerminatedSep 18, 2013ESTRIOL 5 MG/ML OIL INJ SOLNLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-957-2013Class IITerminatedSep 18, 2013ESTRADIOL VALERATE W/ LIDOCAINE 1% 40 MG/ML OIL INJ SOLNLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-956-2013Class IITerminatedSep 18, 2013ESTRADIOL CYPIONATE 5Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-955-2013Class IITerminatedSep 18, 2013ESTRADIOL CYP/PROG/TEST CYP 0.5/10/10 MG/ML OIL INJ SOLNLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-954-2013Class IITerminatedSep 18, 2013EDETATE DISODIUM 150 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-953-2013Class IITerminatedSep 18, 2013DUAL-TESTOSTERONE 20Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-952-2013Class IITerminatedSep 18, 2013DMPS 50mg/ml INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-951-2013Class IITerminatedSep 18, 2013DMSO 50% INJ 50 ML VIAL INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-950-2013Class IITerminatedSep 18, 2013DEXTROSE PF 50% INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-949-2013Class IITerminatedSep 18, 2013DEXPANTHENOL 250 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-948-2013Class IITerminatedSep 18, 2013DEXAMETHASONE SODIUM PHOSPHATE 10 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-947-2013Class IITerminatedSep 18, 2013CYANOCOBALAMIN 1000 MCG/ML INJ SOLNLack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-946-2013Class IITerminatedSep 18, 2013COPPER 0.4MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-945-2013Class IITerminatedSep 18, 2013CHROMIUM 4 MCG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-944-2013Class IITerminatedSep 18, 2013CALCIUM CHLORIDE 100 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-943-2013Class IITerminatedSep 18, 2013BI-TROPIN S-2 INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-942-2013Class IITerminatedSep 18, 2013BI-MIX PHENTOLAMINE/PAPAVERINE 0.5 MG/30 MG/ML and BI-MIX PHENTOLAMINE/PAPAVERINE 1 MG/30 MG/ML INJECTABLELack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assuranceBeacon Hill Medical Pharmacy, P.C. · D-941-2013

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.